International Trade Bulletin - Volume 1, Issue 7
Client Alert | 1 min read | 06.12.06
Inside this issue:
- EUROPE IN THE SPOTLIGHT
- CUSTOMS IN THE SPOTLIGHT
- REGULATIONS: Recent Regulations Proposed by Department of State Will Make U.S. Agency Regulators More Accountable for Regulatory Commitments Abroad
- PHARMACEUTICALS: Pharmaceutical Companies May Face Override of Patent Rights for Public Health Concerns
- FREE TRADE AGREEMENTS: Multi-National Firms Use Southeast Asian FTAs to Enter Indian Markets Demonstrating the Benefits of FTAs to Non-FTA Party Companies
- WTO: New Agreement Among WTO Members Could Allow Foreign Companies Greater Access to Taiwan's Government Procurement Market
- ANTI-DUMPING IN THE EU : European Commissioner for Trade, Peter Mandleson, announces review to decide the best way of balancing competing commercial interests in enforcing EU anti-dumping policy
- EXPORT CONTROLS: BIS Reaffirms Deemed Export Rules By Formally Withdrawing Advance Notice of Proposed Rulemaking
- C-TPAT: C-TPAT Establishes Mandatory Security Link Portal
Contacts
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
Client Alert | 4 min read | 04.16.26
ROI Tracking as Mens Rea? Novartis Ruling Reframes AKS Pleading Risk
